U.S. Rep. Jake LaTurner Recognizes Pharmacy Value, Access in Productive NACDS RxIMPACT Pharmacy Tour
NACDS RxIMPACT pharmacy tours are back in action — and reports from the field have been extremely positive.
NACDS RxIMPACT Pharmacy Tours Showcase Pharmacy Value, Urge Congressional Action on Key Pharmacy Issues
NACDS member pharmacies and pharmacy teams are demonstrating tremendous leadership by hosting members of Congress for pharmacy tours as part of the NACDS RxIMPACT grassroots advocacy program.
With DIR Fee Transparency Rule Finalized, NACDS Urges Continued Push for Comprehensive Reform
NACDS insists that comprehensive DIR fee reform now depends on further legislative and regulatory action to improve predictability, fairness, and viability for pharmacies.
NACDS RxIMPACT Pharmacy Tour in Mississippi Focuses on Pharmacy Value, Accessibility; Places Key Pharmacy Issues at Forefront
Darren Herring (left), district director for U.S. Rep. Trent Kelly (R-MS), participated in a Kroger pharmacy tour in Tupelo, MS, where he met with Kroger pharmacy team member Greg Wood (right). To engage your company in the NACDS RxIMPACT Pharmacy Tour Program, please contact Heidi Ecker at Hecker@nacds.org. | Photo Credit: Kroger
More Than 200 Patient Advocates, Healthcare Entities, Companies Urge Finalized Pharmacy DIR Fee Transparency Rule That Would Promote Patient Access, Protect Pharmacy Viability Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”
Groups applaud CMS’ ongoing efforts to address DIR fees; urge further action for comprehensive pharmacy DIR reform that “reduce[s] [Medicare] beneficiary drug costs and also protect[s] pharmacy access”.
NACDS Expresses Support for CMS’ Pharmacy DIR Fee Transparency Proposal, Urges Additional Actions to Achieve Comprehensive Pharmacy DIR Reform, Protect Patients’ Access to Care NACDS comment letter to Biden Administration urges CMS to finalize proposal, implement regulatory guardrails and standardized pharmacy measures that best serve Medicare patients and help protect pharmacy viability.
NACDS comment letter to Biden Administration urges CMS to finalize proposal, implement regulatory guardrails and standardized pharmacy measures that best serve Medicare patients and help protect pharmacy viability.
NACDS Welcomes Biden Administration’s Action to Confront Dire “DIR Fees” That Inflate Seniors’ Drug Costs and Jeopardize Pharmacies’ Viability NACDS to prepare recommendations to maximize this historic opportunity to reduce seniors’ out-of-pocket drug costs and to help preserve critical, convenient and equitable pharmacy access
NACDS to prepare recommendations to maximize this historic opportunity to reduce seniors’ out-of-pocket drug costs and to help preserve critical, convenient and equitable pharmacy access.
An “Obvious Miss” for Seniors’ Drug Savings: NACDS Hits Lack of Pharmacy DIR Fee Reform in Current Budget Reconciliation Bill
NACDS today said that omitting pharmacy direct and indirect remuneration (DIR) fee reforms from the Build Back Better Act budget reconciliation bill will deprive Medicare beneficiaries of between $7.1 and $9.2 billion over 10 years in reduced cost-sharing for prescription drugs, according to Centers for Medicare and Medicaid Services (CMS) estimates.
Stakeholders Make Push for Pharmacy DIR Reform 249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions
249 organizations sign letter urging Congress to reduce senior drug costs by addressing backdoor pharmacy price concessions.
In Case You Missed It: Government Says DIR Fees That Harm Seniors and Pharmacies Have Skyrocketed by 91,500%
Direct and indirect remuneration (DIR) fees continue to rise at an alarming rate, inflating seniors’ out-of-pocket prescription drug costs and jeopardizing the viability of pharmacies and patient access.
